Enhanced Implantable Cellular and Biotherapeutic Agent Delivery Canister

An advanced implantable canister with dynamic pore size adjustment, microfluidic control, bioactive coatings, integrated sensors, and modular design, enabling more efficient, safe, and targeted delivery of cellular and biotherapeutic agents for tissue repair and regeneration.

The original patent disclosed a metallic, nanoporous device for encapsulating cellular and biotherapeutic agents. However, it had limitations in terms of diffusion control, biocompatibility, and adaptability. The new inventive concept addresses these limitations by introducing innovative features that enhance the performance, safety, and versatility of the implantable canister.

The enhanced implantable canister features a dynamic pore size adjustment mechanism, allowing for real-time control of metabolically active agent diffusion. An internal microfluidic system enables precise control over the delivery of biotherapeutic agents, reducing the risk of agent degradation. A bioactive coating is applied to the surface, promoting tissue integration and reducing the risk of adverse reactions. An integrated sensor system monitors in vivo conditions and adjusts the delivery of biotherapeutic agents accordingly, ensuring optimal therapeutic efficacy. The modular design comprises interchangeable components with varying nanoporous structures, allowing for tailored therapy and minimizing the need for repeated surgical interventions.

The new claims introduce significant improvements over the original patent, including dynamic pore size adjustment, microfluidic control, bioactive coatings, integrated sensors, and modular design. These features provide a non-obvious solution to the limitations of the original patent, offering enhanced performance, safety, and versatility.

Alternative embodiments may include varying the material composition of the implantable canister, incorporating additional sensors or actuators, or integrating the device with external control systems. Variations may also include different nanoporous structures, surface coatings, or microfluidic designs to accommodate diverse therapeutic applications.

The enhanced implantable canister has significant commercial potential in the fields of regenerative medicine, tissue engineering, and personalized therapy. Target industries include pharmaceutical companies, medical device manufacturers, and biotechnology startups, with potential applications in treating a range of diseases and conditions, including cancer, diabetes, and cardiovascular disorders.